• レポートコード:QYR2104Z4560 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、96ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥565,500 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥848,250 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、医薬品連続生産のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(医薬品有効成分、生物製剤、乾燥粉末)、用途別市場規模(製薬会社、医薬品製造受託機関)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・医薬品連続生産の市場動向 ・企業の競争状況、市場シェア ・医薬品連続生産の種類別市場規模(医薬品有効成分、生物製剤、乾燥粉末) ・医薬品連続生産の用途別市場規模(製薬会社、医薬品製造受託機関) ・医薬品連続生産の北米市場規模2016-2027(アメリカ、カナダ) ・医薬品連続生産のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・医薬品連続生産のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・医薬品連続生産の中南米市場規模2016-2027(メキシコ、ブラジル) ・医薬品連続生産の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Siemens、Corning Life Sciences、GEA Group、S K Biotek、Scott Equipment Company、Korsch、Continuus Pharmaceuticals、Chemtrix) ・結論 |
In pharmaceutical continuous manufacturing technology, active ingredients are produced in compact, closed units, leveraging automation. Hence, it requires fewer manual interventions. Production steps carried out sequentially in a classic batch process are combined in a continuous process. All these help to bring about continued utilization of production capacity. This in turn serves to reduce fluctuations in production, improve yields, and lower costs of operation and equipment. On account of such advantages, the method is seeing fast adoption.
Market Analysis and Insights: Global Pharmaceutical Continuous Manufacturing Market
The global Pharmaceutical Continuous Manufacturing market size is projected to reach US$ 2514 million by 2026, from US$ 1781 million in 2019, at a CAGR of 5.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Continuous Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Continuous Manufacturing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Continuous Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Continuous Manufacturing market.
Global Pharmaceutical Continuous Manufacturing Scope and Market Size
Pharmaceutical Continuous Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Continuous Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Active Pharmaceutical Ingredient
Biologics
Dry Powders
Segment by Application
Pharmaceutical Companies
Contract Manufacturing Organization
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Siemens
Corning Life Sciences
GEA Group
S K Biotek
Scott Equipment Company
Korsch
Continuus Pharmaceuticals
Chemtrix
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Continuous Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Active Pharmaceutical Ingredient
1.2.3 Biologics
1.2.4 Dry Powders
1.3 Market by Application
1.3.1 Global Pharmaceutical Continuous Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organization
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Continuous Manufacturing Market Perspective (2016-2027)
2.2 Pharmaceutical Continuous Manufacturing Growth Trends by Regions
2.2.1 Pharmaceutical Continuous Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutical Continuous Manufacturing Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutical Continuous Manufacturing Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutical Continuous Manufacturing Industry Dynamic
2.3.1 Pharmaceutical Continuous Manufacturing Market Trends
2.3.2 Pharmaceutical Continuous Manufacturing Market Drivers
2.3.3 Pharmaceutical Continuous Manufacturing Market Challenges
2.3.4 Pharmaceutical Continuous Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Continuous Manufacturing Players by Revenue
3.1.1 Global Top Pharmaceutical Continuous Manufacturing Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutical Continuous Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Continuous Manufacturing Revenue
3.4 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio
3.4.1 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Continuous Manufacturing Revenue in 2020
3.5 Pharmaceutical Continuous Manufacturing Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Continuous Manufacturing Product Solution and Service
3.7 Date of Enter into Pharmaceutical Continuous Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Continuous Manufacturing Breakdown Data by Type
4.1 Global Pharmaceutical Continuous Manufacturing Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Type (2022-2027)
5 Pharmaceutical Continuous Manufacturing Breakdown Data by Application
5.1 Global Pharmaceutical Continuous Manufacturing Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmaceutical Continuous Manufacturing Market Size (2016-2027)
6.2 North America Pharmaceutical Continuous Manufacturing Market Size by Type
6.2.1 North America Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2027)
6.3 North America Pharmaceutical Continuous Manufacturing Market Size by Application
6.3.1 North America Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2027)
6.4 North America Pharmaceutical Continuous Manufacturing Market Size by Country
6.4.1 North America Pharmaceutical Continuous Manufacturing Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutical Continuous Manufacturing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pharmaceutical Continuous Manufacturing Market Size (2016-2027)
7.2 Europe Pharmaceutical Continuous Manufacturing Market Size by Type
7.2.1 Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2027)
7.3 Europe Pharmaceutical Continuous Manufacturing Market Size by Application
7.3.1 Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2027)
7.4 Europe Pharmaceutical Continuous Manufacturing Market Size by Country
7.4.1 Europe Pharmaceutical Continuous Manufacturing Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutical Continuous Manufacturing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceutical Continuous Manufacturing Market Size (2016-2027)
9.2 Latin America Pharmaceutical Continuous Manufacturing Market Size by Type
9.2.1 Latin America Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutical Continuous Manufacturing Market Size by Application
9.3.1 Latin America Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutical Continuous Manufacturing Market Size by Country
9.4.1 Latin America Pharmaceutical Continuous Manufacturing Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutical Continuous Manufacturing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Siemens Business Overview
11.1.3 Siemens Pharmaceutical Continuous Manufacturing Introduction
11.1.4 Siemens Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021)
11.1.5 Siemens Recent Development
11.2 Corning Life Sciences
11.2.1 Corning Life Sciences Company Details
11.2.2 Corning Life Sciences Business Overview
11.2.3 Corning Life Sciences Pharmaceutical Continuous Manufacturing Introduction
11.2.4 Corning Life Sciences Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021)
11.2.5 Corning Life Sciences Recent Development
11.3 GEA Group
11.3.1 GEA Group Company Details
11.3.2 GEA Group Business Overview
11.3.3 GEA Group Pharmaceutical Continuous Manufacturing Introduction
11.3.4 GEA Group Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021)
11.3.5 GEA Group Recent Development
11.4 S K Biotek
11.4.1 S K Biotek Company Details
11.4.2 S K Biotek Business Overview
11.4.3 S K Biotek Pharmaceutical Continuous Manufacturing Introduction
11.4.4 S K Biotek Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021)
11.4.5 S K Biotek Recent Development
11.5 Scott Equipment Company
11.5.1 Scott Equipment Company Company Details
11.5.2 Scott Equipment Company Business Overview
11.5.3 Scott Equipment Company Pharmaceutical Continuous Manufacturing Introduction
11.5.4 Scott Equipment Company Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021)
11.5.5 Scott Equipment Company Recent Development
11.6 Korsch
11.6.1 Korsch Company Details
11.6.2 Korsch Business Overview
11.6.3 Korsch Pharmaceutical Continuous Manufacturing Introduction
11.6.4 Korsch Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021)
11.6.5 Korsch Recent Development
11.7 Continuus Pharmaceuticals
11.7.1 Continuus Pharmaceuticals Company Details
11.7.2 Continuus Pharmaceuticals Business Overview
11.7.3 Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Introduction
11.7.4 Continuus Pharmaceuticals Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021)
11.7.5 Continuus Pharmaceuticals Recent Development
11.8 Chemtrix
11.8.1 Chemtrix Company Details
11.8.2 Chemtrix Business Overview
11.8.3 Chemtrix Pharmaceutical Continuous Manufacturing Introduction
11.8.4 Chemtrix Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021)
11.8.5 Chemtrix Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pharmaceutical Continuous Manufacturing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Active Pharmaceutical Ingredient
Table 3. Key Players of Biologics
Table 4. Key Players of Dry Powders
Table 5. Global Pharmaceutical Continuous Manufacturing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmaceutical Continuous Manufacturing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pharmaceutical Continuous Manufacturing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pharmaceutical Continuous Manufacturing Market Share by Regions (2016-2021)
Table 9. Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pharmaceutical Continuous Manufacturing Market Share by Regions (2022-2027)
Table 11. Pharmaceutical Continuous Manufacturing Market Trends
Table 12. Pharmaceutical Continuous Manufacturing Market Drivers
Table 13. Pharmaceutical Continuous Manufacturing Market Challenges
Table 14. Pharmaceutical Continuous Manufacturing Market Restraints
Table 15. Global Pharmaceutical Continuous Manufacturing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pharmaceutical Continuous Manufacturing Market Share by Players (2016-2021)
Table 17. Global Top Pharmaceutical Continuous Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Continuous Manufacturing as of 2020)
Table 18. Ranking of Global Top Pharmaceutical Continuous Manufacturing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pharmaceutical Continuous Manufacturing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmaceutical Continuous Manufacturing Product Solution and Service
Table 22. Date of Enter into Pharmaceutical Continuous Manufacturing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Type (2016-2021)
Table 26. Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pharmaceutical Continuous Manufacturing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Application (2016-2021)
Table 30. Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pharmaceutical Continuous Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pharmaceutical Continuous Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pharmaceutical Continuous Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pharmaceutical Continuous Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pharmaceutical Continuous Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pharmaceutical Continuous Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Siemens Company Details
Table 63. Siemens Business Overview
Table 64. Siemens Pharmaceutical Continuous Manufacturing Product
Table 65. Siemens Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021) & (US$ Million)
Table 66. Siemens Recent Development
Table 67. Corning Life Sciences Company Details
Table 68. Corning Life Sciences Business Overview
Table 69. Corning Life Sciences Pharmaceutical Continuous Manufacturing Product
Table 70. Corning Life Sciences Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021) & (US$ Million)
Table 71. Corning Life Sciences Recent Development
Table 72. GEA Group Company Details
Table 73. GEA Group Business Overview
Table 74. GEA Group Pharmaceutical Continuous Manufacturing Product
Table 75. GEA Group Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021) & (US$ Million)
Table 76. GEA Group Recent Development
Table 77. S K Biotek Company Details
Table 78. S K Biotek Business Overview
Table 79. S K Biotek Pharmaceutical Continuous Manufacturing Product
Table 80. S K Biotek Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021) & (US$ Million)
Table 81. S K Biotek Recent Development
Table 82. Scott Equipment Company Company Details
Table 83. Scott Equipment Company Business Overview
Table 84. Scott Equipment Company Pharmaceutical Continuous Manufacturing Product
Table 85. Scott Equipment Company Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021) & (US$ Million)
Table 86. Scott Equipment Company Recent Development
Table 87. Korsch Company Details
Table 88. Korsch Business Overview
Table 89. Korsch Pharmaceutical Continuous Manufacturing Product
Table 90. Korsch Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021) & (US$ Million)
Table 91. Korsch Recent Development
Table 92. Continuus Pharmaceuticals Company Details
Table 93. Continuus Pharmaceuticals Business Overview
Table 94. Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Product
Table 95. Continuus Pharmaceuticals Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021) & (US$ Million)
Table 96. Continuus Pharmaceuticals Recent Development
Table 97. Chemtrix Company Details
Table 98. Chemtrix Business Overview
Table 99. Chemtrix Revenue in Pharmaceutical Continuous Manufacturing Business (2016-2021) & (US$ Million)
Table 100. Chemtrix Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Continuous Manufacturing Market Share by Type: 2020 VS 2027
Figure 2. Active Pharmaceutical Ingredient Features
Figure 3. Biologics Features
Figure 4. Dry Powders Features
Figure 5. Global Pharmaceutical Continuous Manufacturing Market Share by Application: 2020 VS 2027
Figure 6. Pharmaceutical Companies Case Studies
Figure 7. Contract Manufacturing Organization Case Studies
Figure 8. Pharmaceutical Continuous Manufacturing Report Years Considered
Figure 9. Global Pharmaceutical Continuous Manufacturing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pharmaceutical Continuous Manufacturing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pharmaceutical Continuous Manufacturing Market Share by Regions: 2020 VS 2027
Figure 12. Global Pharmaceutical Continuous Manufacturing Market Share by Regions (2022-2027)
Figure 13. Global Pharmaceutical Continuous Manufacturing Market Share by Players in 2020
Figure 14. Global Top Pharmaceutical Continuous Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Continuous Manufacturing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pharmaceutical Continuous Manufacturing Revenue in 2020
Figure 16. Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Type (2016-2021)
Figure 17. Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Type (2022-2027)
Figure 18. North America Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pharmaceutical Continuous Manufacturing Market Share by Type (2016-2027)
Figure 20. North America Pharmaceutical Continuous Manufacturing Market Share by Application (2016-2027)
Figure 21. North America Pharmaceutical Continuous Manufacturing Market Share by Country (2016-2027)
Figure 22. United States Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pharmaceutical Continuous Manufacturing Market Share by Type (2016-2027)
Figure 26. Europe Pharmaceutical Continuous Manufacturing Market Share by Application (2016-2027)
Figure 27. Europe Pharmaceutical Continuous Manufacturing Market Share by Country (2016-2027)
Figure 28. Germany Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Share by Region (2016-2027)
Figure 38. China Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pharmaceutical Continuous Manufacturing Market Share by Type (2016-2027)
Figure 46. Latin America Pharmaceutical Continuous Manufacturing Market Share by Application (2016-2027)
Figure 47. Latin America Pharmaceutical Continuous Manufacturing Market Share by Country (2016-2027)
Figure 48. Mexico Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Share by Country (2016-2027)
Figure 54. Turkey Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Siemens Revenue Growth Rate in Pharmaceutical Continuous Manufacturing Business (2016-2021)
Figure 58. Corning Life Sciences Revenue Growth Rate in Pharmaceutical Continuous Manufacturing Business (2016-2021)
Figure 59. GEA Group Revenue Growth Rate in Pharmaceutical Continuous Manufacturing Business (2016-2021)
Figure 60. S K Biotek Revenue Growth Rate in Pharmaceutical Continuous Manufacturing Business (2016-2021)
Figure 61. Scott Equipment Company Revenue Growth Rate in Pharmaceutical Continuous Manufacturing Business (2016-2021)
Figure 62. Korsch Revenue Growth Rate in Pharmaceutical Continuous Manufacturing Business (2016-2021)
Figure 63. Continuus Pharmaceuticals Revenue Growth Rate in Pharmaceutical Continuous Manufacturing Business (2016-2021)
Figure 64. Chemtrix Revenue Growth Rate in Pharmaceutical Continuous Manufacturing Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed